Fig. 6 | Scientific Reports

Fig. 6

From: Early evaluation of anti-angiogenic effects with gadolinium(III) labeled APN/CD13 specific binding peptides magnetic resonance imaging

Fig. 6

Immunohistochemical staining of ANP/CD13 expression in transplanted tumors. HT-29 grafts (A, B) exhibited no significant expression of ANP/CD13, whereas HT-1080 grafts demonstrated high expression of ANP/CD13 prior to treatment with ubenimex (indicated by arrows). Expression of ANP/CD13 was markedly reduced at 7 days post-treatment with ubenimex (indicated by arrows) (20×).

Back to article page